近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Wang, Y.Y., L.J. Zhao, C.F. Wu, P. Liu, L. Shi, Y. Liang, S.M. Xiong, J.Q. Mi, Z. Chen, R. Ren (co-corresponding author), S.J. Chen.. "C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice.." Proc. Natl. Acad. Sci. USA. 108. (2011): 2450-5. Cuiffo, B., Ren, R.. "Palmitoylation of oncogenic NRAS is essential for leukemogenesis." Blood 115. (2010): 3598-605. Cuiffo, B., Ren, R.. "Palmitoylation of oncogenic NRAS is essential for leukemogenesis." Blood Epub. (2010). Jo, S., J. Schatz, J. Acquaviva, H. Singh and R. Ren.. "Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis.." Blood. 116. (2010): 2759-67.. Jagani, Z., Song, K., Kutok, J. L., Dewar, M. R., Melet, A., Santos, T., Grassian, A., Ghaffari, S., Wu, C., Yeckes-Rodin, H., Ren, R., Miller, K., Khosravi-Far, R.. "Proteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressors." Cancer Res 69. 16 (2009): 6546-55. Acquaviva, J., Chen, X., Ren, R.. "IRF-4 functions as a tumor suppressor in early B-cell development." Blood 112. 9 (2008): 3798-806. Baum, K. J., Ren, R.. "Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis." J Hematol Oncol 1. (2008): 5. Parikh, C., Ren, R.. "Mouse model for NRAS-induced leukemogenesis." Methods Enzymol 439. (2008): 15-24. Zhang, S. J., Ma, L. Y., Huang, Q. H., Li, G., Gu, B. W., Gao, X. D., Shi, J. Y., Wang, Y. Y., Gao, L., Cai, X., Ren, R. B., Zhu, J., Chen, Z., Chen, S. J.. "Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia." Proc Natl Acad Sci U S A 105. 6 (2008): 2076-81. Zhang, S. J., Ma, L. Y., Huang, Q. H., Li, G., Gu, B. W., Gao, X. D., Shi, J. Y., Wang, Y. Y., Gao, L., Cai, X., Ren, R. B., Zhu, J., Chen, Z., Chen, S. J.. "Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia." Proc Natl Acad Sci U S A 105. 6 (2008): 2076-81. Parikh, C., Subrahmanyam, R., Ren, R.. "Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice." Cancer Res 67. 15 (2007): 7139-46. Yan, M., Luo, J.K., Ritchie, K.J., Sakai, I., Takeuchi, K., Ren, R., Zhang, D.E.. "Ubp43 regulates BCR-ABL leukemogenesis via the Type I interferon receptor signaling.." Blood 110. (2007): 305-312. Cuiffo, B., Ren, R.. "Models of hematopoietic malignancies: chronic myeloid leukemia.." Drug Discovery Today 3. (2006): 183-189. Parikh, C., Subrahmanyam, R., Ren, R.. "Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice." Blood 108. 7 (2006): 2349-57. Shackelford, D., Kenific, C., Blusztajn, A., Waxman, S., Ren, R.. "Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide." Cancer Res 66. 23 (2006): 11360-9. Ren, Ruibao and Perera, S.A lY. Ji, A.W.Gross. "TEL/ABL induces CML-Like myeloproliferative disorder versus a small bowel disease in mice in a dose-dependent manner." Blood (2005). Ren, Ruibao and Subrahmanyam, R., C. Parikh. "Oncogenic N-Ras rapidly and efficiently induces CMML-and AML-like diseases in mice." Blood (2005). Ren, Ruibao. "Mechanisms of BCR? ll-{ABL in the pathogenesis of chronic myelogenous leukemia." Nature Reviews Cancer (2005). Ren,Ruibao. "Molecular mechanism of chronic myelogenous leukemia." Nature Reviews Cancer (2004). Ren,Ruibao. "R. Ren Restraing CML by adhesives.." Blood (2004). Ren, Ruibao and Cuenco, G. M.. "Both AML1 and EVI1 oncogenic components are required to the cooperation of AML1/MDS1/EVI1 with BCR/ABL in induction of acute myelogenous leukemia in mice." Oncogene 23. (2003): 569-79. Ren, Ruibao, Dinulescu, D. M., L. J. Wood, L. Shen, M. Loriaux, C. L. Corless, A. W. Gross, M. W..N. Deininger & B. J. Druker. "c-CBL is not required for leukemia induction by Bcr-Abl in mice." Oncogene 22. (2003): 8852-60. Ren, Ruibao. "Modeling the dosage effect of oncogenes in leukemogenesis." Current Opinion in Hematology 11. (2003): 25-34. Ren,Ruibao. "Overriding BCR/ABL mitotic signal by ICSBP-induced differentiation." Blood 102. (2003): 4251-52.